MLchartDataset catalogue

Onrigin

Term · Oncology and biomedicine · MLC-T-ONC-006083

A drug used to treat acute myelogenous leukemia (AML). It is also being studied in the treatment of several other types of cancer. It blocks cell growth by damaging the cell’s DNA and may kill cancer cells. It is a type of alkylating agent. Also called Cloretazine and laromustine.

Table 1. Record
IdentifierMLC-T-ONC-006083
FieldOncology and biomedicine
SynonymsCloretazine; laromustine
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-006083",
  "term": "Onrigin",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat acute myelogenous leukemia (AML). It is also being studied in the treatment of several other types of cancer. It blocks cell growth by damaging the cell’s DNA and may kill cancer cells. It is a type of alkylating agent. Also called Cloretazine and laromustine.",
  "synonyms": [
    "Cloretazine",
    "laromustine"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/onrigin/"
}

Record 12,245 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.